Cart
sales@molnova.com
WHI-P180
CAS No. 211555-08-7
WHI-P180 ( Janex 3 )
Catalog No. M13366 CAS No. 211555-08-7
WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 51 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 124 | In Stock |
|
| 25MG | 210 | In Stock |
|
| 50MG | 311 | In Stock |
|
| 100MG | 461 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWHI-P180
-
NoteResearch use only, not for human use.
-
Brief DescriptionWHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
-
DescriptionWHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
-
SynonymsJanex 3
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK2; EGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number211555-08-7
-
Formula Weight297.31
-
Molecular FormulaC16H15N3O3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESOC1=CC=CC(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)=C1
-
Chemical Name3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An R, et al. Pharm Res. 2009 Feb;26(2):449-58.
molnova catalog
related products
-
Ribociclib succinate
Ribociclib succinate is a highly specific CDK4/6 inhibitor (IC50: 10 nM and 39 nM, respectively). It also is over 1,000-fold less potent against the cyclin B/CDK1 complex.
-
ICEC 0942 hydrochlor...
ICEC 0942 (CT7001) is a potent, selective, orally active CDK7 inhibitor with IC50 of 41 nM, displays 15-fold selectivity over CDK2 (IC50=578 nM).
-
PHA-793887
A potent inhibitor of CDK2/5/7 with IC50 of 8/5/10 nM respectively; >6-fold less potency on CDK1/4/7.
